Methods: Cross-sectional description on 1022 beta thalassemia carriers at the National Institute of Hematology and Blood Transfusion from 2015 to 8/2020 who were tested for total blood cell analysis, fe, blood ferritin serum, hemoglobin type, and beta thalassemia gene mutations.